---
figid: PMC8126328__cgp-18-215-g0001
figtitle: G-Protein-coupled Estrogen Receptor 1 Agonist G-1 Perturbs Sunitinib Resistance-related
  Phosphoproteomic Signatures in Renal Cell Carcinoma
organisms:
- NA
pmcid: PMC8126328
filename: cgp-18-215-g0001.jpg
figlink: ''
number: F1
caption: 'Figure 4. G-Protein-coupled estrogen receptor 1 agonist G-1 perturbed phosphorylation
  networks. Significantly altered selected phosphosites were analyzed by PhosphoPath.
  Enriched phosphorylation networks from vascular endothelial growth factor A-vascular
  endothelial growth factor receptor 2 (VEGFA-VEGFR2) pathway (A), focal adhesion-phosphoinositide
  3-kinase-protein kinase B-mammalian target of rapamycin (PIK3-AKT-mTOR) signaling
  pathway (B), and cell-cycle checkpoint (C) are shown. The relative expression of
  each phosphosite is indicated by small colored boxes from left to right in: Sunitinib-resistant
  (SunR), G-1-treated parental, G-1-treated SunR vs. untreated SunR, and G-1-treated
  SunR 786-O cells, with red and green colors denoting up-regulation and down-regulation,
  respectively'
papertitle: G-Protein-coupled Estrogen Receptor 1 Agonist G-1 Perturbs Sunitinib Resistance-related
  Phosphoproteomic Signatures in Renal Cell Carcinoma.
reftext: SHAO-KUAN CHEN, et al. Cancer Genomics Proteomics. 2021 May-Jun;18(3):207-220.
year: '2021'
doi: 10.21873/cgp.20253
journal_title: Cancer Genomics & Proteomics
journal_nlm_ta: Cancer Genomics Proteomics
publisher_name: International Institute of Anticancer Research
keywords: G-Protein-coupled estrogen receptor 1 | renal cell carcinoma | sunitinib
  resistance | quantitative phosphoproteomics
automl_pathway: 0.8157901
figid_alias: PMC8126328__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8126328__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8126328__cgp-18-215-g0001.html
  '@type': Dataset
  description: 'Figure 4. G-Protein-coupled estrogen receptor 1 agonist G-1 perturbed
    phosphorylation networks. Significantly altered selected phosphosites were analyzed
    by PhosphoPath. Enriched phosphorylation networks from vascular endothelial growth
    factor A-vascular endothelial growth factor receptor 2 (VEGFA-VEGFR2) pathway
    (A), focal adhesion-phosphoinositide 3-kinase-protein kinase B-mammalian target
    of rapamycin (PIK3-AKT-mTOR) signaling pathway (B), and cell-cycle checkpoint
    (C) are shown. The relative expression of each phosphosite is indicated by small
    colored boxes from left to right in: Sunitinib-resistant (SunR), G-1-treated parental,
    G-1-treated SunR vs. untreated SunR, and G-1-treated SunR 786-O cells, with red
    and green colors denoting up-regulation and down-regulation, respectively'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FXR2
  - USP10
  - USP32
  - PPP2R5D
  - EIF4G2
  - PRKCD
  - SKIC3
  - RICTOR
  - PAK4
  - TSC1
  - CCL26
  - VCL
  - NCL
  - DNAJC5
  - TH
  - EIF4G1
  - RPS6
  - PRKAA1
  - MTOR
  - SET
  - TSC2
  - AKT1S1
  - PRKCI
  - PPP2CA
  - EPHA2
  - ANXA1
  - PRKCA
  - CAV1
  - PALM2AKAP2
  - TLN1
  - ATF2
  - GDNF
  - SND1
  - FLNB
  - MYH9
  - RPLP2
  - GIGYF2
  - FRZB
  - RBM39
  - NEXN
  - RPTOR
  - JUN
  - JUNB
  - JUND
  - FLII
  - CTNNB1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PRKAA2
  - RAB14
  - GRB10
  - LRRFIP2
  - EGFR
  - MAP2K2
  - HSP90AA1
  - CRTC2
  - PRKCE
  - CAV2
  - ABL1
  - EPS15
  - SRC
  - FGR
  - FYN
  - YES1
  - RAF1
  - RNASE3
  - GTF2IRD1
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - HSP90AB1
  - PFKFB3
  - ACTN4
  - EPHA1
  - EPHA3
  - EPHA4
  - EPHA5
  - EPHA6
  - EPHA7
  - EPHA8
  - EPHA10
  - MAP2K3
  - MAP2K4
  - MAP2K5
  - MAP2K6
  - MAP2K7
  - MAP2K1
  - FLNA
  - PAK2
  - PKN2
  - FLNC
  - MYLK
  - PAK1
  - PKN1
  - PXN
  - PXDN
  - NCK1
  - BOC
  - SEPTIN1
  - LARP1
  - MYL12A
  - PML
  - MYL1
  - MYL3
  - MYL4
  - MYL6
  - MYL6B
  - MYL10
  - MYL12B
  - MYL2
  - MYL5
  - MYL7
  - MYL9
  - MYL11
  - ARHGAP35
  - PRPF6
  - EPN1
  - CSF1
  - PPP1R12A
---
